Calyxt Inc Stock News

State Street Corp increased its holdings in Calyxt Inc (NASDAQ:CLXT) by 9.9% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The

Jefferies downgrades 10 'lower conviction' Chemicals stocks to Hold Jefferies ASH AXTA CC CLXT DCI GCP GPRE GRA VNTR VVV

Zacks Investment Research cut shares of Calyxt (NASDAQ:CLXT) from a hold rating to a sell rating in a report issued on Thursday, Zacks.com reports. According to Zacks, “Calyxt, Inc. is a consumer-ce

KBC Group NV increased its holdings in Calyxt Inc (NASDAQ:CLXT) by 3,558.5% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owne

National Securities restated their buy rating on shares of Calyxt (NASDAQ:CLXT) in a research note published on Friday, AnalystRatings.com reports. The brokerage currently has a $16.00 price target on

Wells Fargo & Co downgraded shares of Calyxt (NASDAQ:CLXT) from an overweight rating to an equal weight rating in a research note published on Friday, BenzingaRatingsTable reports. The brokerage curre

Fmr LLC trimmed its stake in shares of Calyxt Inc (NASDAQ:CLXT) by 19.3% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission

Shareholders in Calyxt, Inc. (NASDAQ:CLXT) had a terrible week, as shares crashed 31% to US$4.38 in the week since its...

Zacks Investment Research upgraded shares of Calyxt (NASDAQ:CLXT) from a sell rating to a hold rating in a research note issued to investors on Tuesday, Zacks.com reports. According to Zacks, “Calyx

ACADIA Pharmaceuticals (NASDAQ:ACAD) initiated with Buy rating and $69 (55% upside) price target at Citigroup.Alector (NASDAQ:ALEC) initiated with Buy rating and $40 (36% upside) price target at Citi.

In a report released today, Ben Klieve from National Securities Corp maintained a Buy rating on Calyxt (CLXT), with a price target of $16.00. The

Calyxt, Inc. (NASDAQ:CLXT) Q4 2019 Earnings Conference Call March 05, 2020, 08:30 AM ET Company Participants Chris Tyson - MD, MZ North America, IR Jim Blome -

Calyxt, Inc. (NASDAQ: CLXT), a plant-based technology company, has reported its financial results for the fourth quarter and full year ended December 31, 2019.

Calyxt Inc (NASDAQ:CLXT) Director Yves J. Ribeill sold 9,990 shares of the company’s stock in a transaction that occurred on Friday, February 28th. The stock was sold at an average price of $5.46, f

Calyxt (NASDAQ:CLXT) is scheduled to be issuing its quarterly earnings data before the market opens on Thursday, March 5th. Analysts expect the company to announce earnings of ($0.39) per share for th